Drug Enforcement Administration



Drug Enforcement Administration Recent News

DEA Renews Effort To Place 2 Psychedelics In Strictest Drug Category
Should The Biden Administration Reschedule Cannabis By Year-End? Six Governors Say Yes
DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases
DEA Report Shows Reduced Cannabis Testing Amid Legalization
Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling
Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals
Trulieve CEO: Federal Rescheduling Could Change Heavy Tax Burden For Cannabis Industry
EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
EXCLUSIVE: How Federal Cannabis Reclassification Could Transform Business Finances, Insights From Cresco Labs' CEO
EXCLUSIVE: End Of Weed Prohibition? Fmr Sen Cory Gardner Discusses Potential Cannabis Reclassification
Innovator Embraces Psychedelic Horizons With New Schedule 1 Manufacturing License
At-Home Ketamine Therapy Ending Soon And New Survey Finds Overdosing All Too Common
These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
USDA Delays Enforcement Of Rules Requiring Hemp To Be Tested By DEA-Registered Labs, Here's Why
DEA Announces How Much Marijuana, MDMA, Psilocyn, LSD, Mescaline, 5-MeO-DMT, MDA, 2-CB Can Be Produced For Research In 2023
Psyched: DEA Boosts Research Production, Booker's Psychedelics Reform, Kanye West's George Floyd Comments And More
As DEA Withdraws In Psychedelics Battle Over DOI And DOC, Researchers Win - For Now
Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana
DEA Revokes Project To Schedule 5 New Psychedelic Compounds
DEA Taken To Court Again For Access To Psilocybin For End-Of-Life Care
Federal Health Officials' Letter To Senators: Psychedelics Illegal Status Limits Research
GOP Lawmakers Introduce Bill To Streamline Psychedelics, Cannabis Research After DEA Shows Support For White House Plan
DEA Supports White House Plan To Streamline Research Of Psychedelics and Cannabis